Optimizing patient access with evidence of product value, effectiveness and safety from early development through loss of exclusivity.

Learn More
statistics

Our Work In Action

130+ Payer Submissions

across 20+ countries in the past 5 years, including reversal of multiple NICE decisions

12 of the 15 Top-Selling Drugs

in 2016 supported in the past 5 years

150+ Drugs/Therapies

supported in the past year

30+ Global Extended Access Programs

in the last 3 years alone with thousands of patients transitioning smoothly from investigational to commercial

150+ Peer-Reviewed Publications

and 250+ research posters and presentations per year

Learn More
what-we-do

In Our Own Words

Regulators and payers are increasingly using data on patient preferences, and we support our clients in applying these methods to inform decision making across a product’s entire lifecycle.

CUP-case-study
Case Study

Robust Modeling Helped Convince NICE to Reverse Their Decision

Learn how Evidera’s experts helped to improve access to a mCRPC treatment in a country with traditionally conservative reimbursement for these therapies.

Read More
Case Study

Compassionate Use Program: Rapid Drug Delivery to Patients in Need

Learn how Evidera, as part of PPD, created a global program across 38 countries to provide treatment within 24-48 hours to 3,100 patients.

Read More
Careers

Meaningful Work at Every Level

We assess candidates across a variety of scientific and operational functions. From leaders in their fields, to those who are new to the industry. We employ people who have a proactive mind-set when it comes to the work they do and helping the people they work with.

Learn More
Evidera Carees